MORGAN STANLEY PLC/CALL/CVS HEALTH/77/0.1/20.12.24 Stock

Warrant

DE000MB3FFB2

Market Closed - Börse Stuttgart 14:51:56 2024-07-03 EDT
0.067 EUR -12.99% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/77/0.1/20.12.24
Current month-22.99%
1 month-39.09%
Date Price Change
24-07-03 0.067 -12.99%
24-07-02 0.077 -4.94%
24-07-01 0.081 -6.90%
24-06-28 0.087 +14.47%
24-06-27 0.076 -24.00%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 02:51 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB3FFB
ISINDE000MB3FFB2
Date issued 2023-02-08
Strike 77 $
Maturity 2024-12-20 (170 Days)
Parity 10 : 1
Emission price 1.87
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 2.05
Lowest since issue 0.048
Delta0.12x
Omega 9.275
Premium37.12x
Gearing75.64x
Moneyness 0.7364
Difference Strike 20.3 $
Difference Strike %+26.36%
Spread 0.007
Spread %9.59%
Theoretical value 0.0695
Implied Volatility 35.09 %
Total Loss Probability 91.78 %
Intrinsic value 0.000000
Present value 0.0695
Break even 77.75 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
56.7 USD
Average target price
69.1 USD
Spread / Average Target
+21.86%
Consensus